Article Details
Retrieved on: 2019-09-11 20:11:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>GSK to obtain transglutaminase 2 small molecule program for celiac disease. SAN DIEGO, CA, USA I September 12, 2019 I <b>Avalon Ventures</b> today ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here